Jiping Tang Selected Research

Evans Blue (Blue, Evans)

7/2017	Intranasal administration of vitamin D attenuates blood-brain barrier disruption through endogenous upregulation of osteopontin and activation of CD44/P-gp glycosylation signaling after subarachnoid hemorrhage in rats.
1/2016	Intranasal IGF-1 Reduced Rat Pup Germinal Matrix Hemorrhage.
1/2016	Osteopontin-Rac1 on Blood-Brain Barrier Stability Following Rodent Neonatal Hypoxia-Ischemia.
2/2014	Isoflurane on brain inflammation.
4/2012	Hyperbaric oxygen preconditioning attenuates hyperglycemia enhanced hemorrhagic transformation after transient MCAO in rats.
12/2011	PDGFR-α inhibition preserves blood-brain barrier after intracerebral hemorrhage.
2/2011	Comparison Evans Blue injection routes: Intravenous versus intraperitoneal, for measurement of blood-brain barrier in a mice hemorrhage model.
5/2010	Ginsenoside Rbeta1 reduces neurologic damage, is anti-apoptotic, and down-regulates p53 and BAX in subarachnoid hemorrhage.
11/2009	Matrix metalloproteinases inhibition provides neuroprotection against hypoxia-ischemia in the developing brain.
4/2008	Role of histamine in brain protection in surgical brain injury in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiping Tang Research Topics

Disease

103	Brain Injuries (Brain Injury) 01/2022 - 06/2004
80	Brain Edema (Cerebral Edema) 01/2022 - 10/2004
53	Cerebral Hemorrhage 11/2022 - 10/2004
52	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 10/2021 - 05/2006
47	Hypoxia (Hypoxemia) 01/2022 - 08/2005
37	Inflammation (Inflammations) 12/2021 - 06/2008
34	Neuroinflammatory Diseases 02/2022 - 12/2012
34	Stroke (Strokes) 10/2021 - 05/2009
31	Hemorrhage 05/2020 - 07/2002
29	Ischemia 01/2021 - 08/2005
28	Infarction (Infarctions) 01/2022 - 05/2009
20	Ischemic Stroke 02/2021 - 05/2007
20	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2021 - 07/2010
18	Hematoma 01/2022 - 01/2011
14	Brain Infarction 01/2022 - 09/2011
12	Atrophy 01/2021 - 11/2009
10	Brain Ischemia (Cerebral Ischemia) 05/2020 - 06/2004
9	Hyperglycemia 10/2021 - 06/2011
8	Wounds and Injuries (Trauma) 01/2018 - 03/2007
7	Edema (Dropsy) 12/2020 - 12/2011
7	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 05/2020 - 02/2010
7	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020 - 02/2014
6	Hydrocephalus (Hydrocephaly) 02/2022 - 07/2012
6	Body Weight (Weight, Body) 10/2016 - 01/2008
4	Hemorrhagic Stroke 01/2018 - 03/2010
4	Neurologic Manifestations (Neurological Manifestations) 08/2015 - 10/2004
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 09/2017
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 06/2015
3	Encephalitis (Encephalitis, Rasmussen) 10/2020 - 02/2014
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019 - 01/2018
3	Nervous System Diseases (Neurological Disorders) 06/2018 - 01/2015
3	Rupture 01/2018 - 01/2011
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2017 - 01/2016
3	Intracranial Vasospasm 12/2012 - 07/2002

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 02/2021 - 08/2005
21	salicylhydroxamic acid (SHAM)IBA 01/2019 - 03/2005
20	Neuroprotective AgentsIBA 05/2020 - 03/2009
19	Small Interfering RNA (siRNA)IBA 01/2021 - 12/2012
19	Oxygen (Dioxygen)IBA 01/2018 - 05/2006
17	Collagenases (Collagenase)FDA Link 01/2018 - 10/2004
13	Caspase 3 (Caspase-3)IBA 01/2021 - 04/2008
12	Hemoglobins (Hemoglobin)IBA 09/2021 - 02/2011
12	Isoflurane FDA LinkGeneric 10/2020 - 07/2010
10	fluoro-jade CIBA 01/2022 - 04/2017
10	OsteopontinIBA 01/2020 - 02/2011
10	Evans Blue (Blue, Evans)FDA Link 07/2017 - 04/2008
10	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 06/2011
9	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2015 - 05/2007
8	CateninsIBA 09/2021 - 04/2012
8	CytokinesIBA 02/2021 - 02/2014
8	HydrogenIBA 01/2021 - 01/2011
8	Anesthetics (Anesthetic Agents)IBA 10/2020 - 07/2010
7	Sirtuin 1IBA 10/2021 - 02/2015
6	Tight Junction ProteinsIBA 01/2022 - 11/2009
6	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 09/2013
6	Protein Kinases (Protein Kinase)IBA 01/2021 - 01/2016
6	InflammasomesIBA 01/2021 - 10/2013
6	AntioxidantsIBA 08/2019 - 03/2010
6	Peroxidase (Myeloperoxidase)IBA 01/2018 - 06/2008
5	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 11/2009
5	Immunoglobulin G (IgG)IBA 01/2021 - 04/2008
5	Adenosine Monophosphate (AMP)IBA 10/2020 - 04/2017
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2016 - 02/2010
5	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2007 - 06/2004
4	LigandsIBA 01/2022 - 10/2020
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2021 - 01/2018
4	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2021 - 10/2019
4	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2021 - 10/2004
4	Thrombin FDA Link 01/2021 - 12/2011
4	IntegrinsIBA 01/2021 - 12/2014
4	Imatinib Mesylate (Gleevec)FDA Link 01/2020 - 01/2015
4	EnzymesIBA 08/2019 - 06/2011
4	Phosphotransferases (Kinase)IBA 01/2019 - 05/2013
4	Blood Glucose (Blood Sugar)IBA 07/2018 - 06/2011
4	p38 Mitogen-Activated Protein KinasesIBA 04/2018 - 12/2013
4	TOR Serine-Threonine KinasesIBA 04/2017 - 07/2012
4	Coloring Agents (Dyes)IBA 01/2016 - 02/2011
4	Erythropoietin FDA Link 01/2015 - 10/2011
3	CC ChemokinesIBA 01/2022 - 03/2021
3	BMS-470539IBA 01/2022 - 01/2020
3	NucleotidesIBA 12/2021 - 01/2018
3	InterleukinsIBA 11/2021 - 02/2014
3	Adenosine Triphosphate (ATP)IBA 10/2021 - 05/2009
3	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 10/2021 - 10/2020
3	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 03/2021 - 10/2014
3	NF-kappa B (NF-kB)IBA 01/2021 - 02/2015
3	Pharmaceutical PreparationsIBA 11/2019 - 08/2015
3	Messenger RNA (mRNA)IBA 01/2019 - 06/2004
3	Heme (Haem)IBA 12/2018 - 04/2017
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2018 - 03/2011
3	Glycoproteins (Glycoprotein)IBA 01/2018 - 10/2014
3	Netrin-1IBA 01/2018 - 01/2017
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2016 - 01/2015
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2014 - 06/2008
3	SphingosineIBA 02/2014 - 07/2010

Therapy/Procedure

31	Ligation 01/2022 - 09/2008
30	Therapeutics 01/2021 - 01/2011
10	Neurosurgical Procedures 01/2020 - 03/2007
8	Intranasal Administration 01/2021 - 01/2016
8	Hyperbaric Oxygenation 04/2016 - 01/2008